- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06356792
Obstetrics , Prenatal Outcomes in Recurrent Miscarriage (OBPORPL)
April 4, 2024 updated by: Reem Salah Abdelkareem Ahmed, Assiut University
The Associations Between History of Recurrent Miscarriage and Obstetric and Perinatal Outcomes in the Subsequent Pregnancy
The effect of recurrent miscarriage on the outcome of the current pregnancy and if there's a relation between it and adverse out come
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
102
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Reem Salah Abdelkareem, Master
- Phone Number: 01279438766
- Email: Reemsalah246@gmail.com
Study Locations
-
-
-
Assiut, Egypt
- Recruiting
- Assiut University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
patients who had ≥2 abortions during early pregnancy, patients had no abnormal reproductive tract anatomy , single fetus
Description
Inclusion Criteria:
1- patients who had ≥2 abortions during early pregnancy 2.patients had no abnormal reproductive tract anatomy 3. Pregnant in single fetus
Exclusion criteria:
chronic hypertension, chronic kidney diseases autoimmune diseases multiple pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
If there's relation between recurrent abortion and having a medical disorder during current pregnancy
Time Frame: 2023 to 2025
|
2023 to 2025
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 21, 2024
Primary Completion (Estimated)
March 21, 2025
Study Completion (Estimated)
March 21, 2025
Study Registration Dates
First Submitted
March 21, 2024
First Submitted That Met QC Criteria
April 4, 2024
First Posted (Actual)
April 10, 2024
Study Record Updates
Last Update Posted (Actual)
April 10, 2024
Last Update Submitted That Met QC Criteria
April 4, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Obstetrics outcome in Abortion
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.